Drug monitoring Flashcards
1
Q
Monitoring for statins
A
LFTs:
- at baseline
- 3 months
- 12 months
2
Q
Monitoring for ACE inhibitors
A
- U&E prior to treatment
- U&E after increasing dose
- U&E at least annually
3
Q
Monitoring for Amiodarone
A
- TFT, LFT, U&E, CXR prior to treatment
- TFT, LFT every 6 months
4
Q
Monitoring for Methotrexate
A
- FBC and renal and LFTs before starting treatment
- repeated weekly until therapy stabilised
- thereafter patients should be monitored every 2-3 months
- U&Es
5
Q
Monitoring for Azathioprine
A
- FBC, LFT before treatment
- FBC weekly for the first 4 weeks
- FBC, LFT every 3 months
6
Q
Monitoring for Lithium
A
- TFT, U&E prior to treatment
- Lithium levels weekly until stabilised then every 3 months
- TFT, U&E every 6 months
7
Q
Monitoring for sodium valproate
A
- LFT, FBC before treatment
- LFT‘periodically’ during first 6 months
8
Q
Monitoring for glitazones
A
- LFT before treatment
- LFT ‘regularly’ during treatment
